Transcatheter aortic valve implantation (TAVI) has been touted for “revolutionizing the field of cardiology,” as the preferred treatment for most patients over age 70 years with severe aortic stenosis ...
TAVI was done for the first time in 2002. Since then, TAVI has come a long way. Back in 2012, we were doing TAVI only for patients who were not fit for open heart surgery. But now we have evidence ...
Valve-in-valve (ViV) transcatheter procedures for a failed aortic bioprosthesis are associated with a lower risk of in-hospital mortality compared with a repeat surgical aortic valve replacement, but ...
The first human transcatheter aortic valve implantation (TAVI) in 2002, and several subsequent single-center series, showed the feasibility of this new approach for the treatment of patients with ...
As transcatheter aortic valve implantation (TAVI) gains increasing acceptance, cardiologists and surgeons are exploring additional patient populations who may benefit from the procedure. A new paper ...
Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lacking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results